US Policy Lead
Morpho · Remote · US only
$225k–$295k/yrFull-time

EQL TechRemote · US onlyFull-time
Pay not listed
On EQL Tech’s own careers site (Workable), checked open today.
Summarised from the posting by AI and can be wrong. The full description is the source.
Sign in and add your resume to see which of this job's requirements it shows.
Sign in to check your matchSaved to your account, encrypted. The AI that reads it doesn't keep it or train on it.
Also: paid time off
From EQL Tech’s careers site
About the initiative
Clinical trials in the United States take too long, cost too much, and are too tangled in outdated rules — and the country develops far fewer of the therapies it could. The Clinical Trial Abundance Initiative exists to change that at the root: by reforming the federal policy and law that govern how trials are run, so that high-quality trials become dramatically faster, cheaper, and simpler to conduct.
We are a new, founder-led effort backed by a coalition of leading science philanthropies. The 2027 reauthorization of the Prescription Drug User Fee Act (PDUFA) is a rare, high-leverage window to move real reform — and we are building both the organization and the coalition to make the most of it, and to sustain momentum well beyond it. We draw on what already works abroad, from Australia's notification-based trial pathway to reforms across the UK and elsewhere.
What this role is — and isn't
This is a policy and law reform role, not an operations or access role. The work is to change the rules — the federal policy and law governing clinical trials — so that more trials can be launched, run, and approved, faster and at lower cost.
To be direct about scope: you will not be operating or running trials, and the role is not focused on trial access, diversity, inclusion, or equity. Those aims matter, but they are a different kind of work. This role exists to make trials themselves faster, cheaper, and more abundant to conduct — by reforming the system that governs them.
The role
This is a founding leadership role, working in close partnership with the initiative's Chief Science Officer to build the effort from the ground up. It runs on two horizons at once.
In the near term, you are the initiative's credible face in policy — the person who can sit across from a Senate HELP or House Energy & Commerce staffer, an FDA official, a hospital system's leadership, or a biotech CEO, and be taken seriously by all of them. You help shape the legislative and regulatory reform agenda and drive it into the PDUFA 2027 window and its implementation.
Over the medium term, you build the field. There is no standing constituency for clinical trial abundance today; your job is to create one — a durable, formidable coalition of companies, investors, researchers, patient organizations, and policymakers who will carry this work long after any single legislative moment.
What you'll do
Requirements
Who you are
Nice to have
Benefits
Something wrong with this job? Report it · This flag looks wrong

Morpho · Remote · US only
$225k–$295k/yrFull-time
StrongChecked open todayPosted 1 month ago

Pathward, N.A. · Remote · US only
$90k–$120k/yrFull-time
StrongChecked open todayPosted 18 days ago

Blue Rose Research · Remote · US only
$5,000–$20,000/mo · see posting
Wide pay rangeChecked open todayPosted 24 days ago

AlphaX · Remote · US only
Contract
StrongPay not listedLast seen open yesterdayPosted 1 month ago

WeaveGrid, Inc. · Remote · US only
$110k–$156k/yrFull-time
StrongOpen 2 monthsChecked open todayPosted 2 months ago

Zero to Three · Remote · US only
$80k/yr
StrongChecked open todayPosted 9 days ago